Clinical trials: Fruquintinib Capsules
Patient Safety
A Phase IV Study of Elunate® (Fruquintinib) in Chinese Patients
A phase IV study to characterize safety of Elunate® (Fruquintinib) in Chinese patients
- Trial name
- NCT04005066
- Testing
- Elunate®
- Where
- China
- Volunteers
- 3,005 people
- Sponsor
- Hutchmed
Colorectal Cancer
A Study to Monitor the Fruzaqla Treatment of Adults With Metastatic Colorectal Cancer (mCRC) in South Korea
The purpose of this study is to estimate the proportion of all adverse events (AEs) including serious adverse events (SAEs) occurring with the use of fruquintinib among adult participants who have been administered fruquintinib…
- Trial name
- NCT07035886
- Testing
- No intervention
- Where
- South Korea
- Volunteers
- 600 people
- Sponsor
- Takeda